Prescribing issues to address

Quality prescribing strategy for respiratory: a guide for improvement
Scottish Government Effective Prescribing & Therapeutics Division
Polypharmacy icon of two pills
  • The indicators included are priority areas of prescribing where there is variation within NHS Boards
  • Ensuring COPD medicines are reviewed and optimised may support the reduction of unwarranted variation
  • The indicators focus on ensuring quality prescribing and any recommendations made follow national clinical guidance
  • PIS Prescribing data cannot be separated by diagnosis however the Scottish Therapeutics Utility (STU) software enables GP practices to identify patients with Asthma or COPD. (See 'Scottish Therapeutics Utility (STU)')

 

Prescribing of inhaled high dose corticosteroids

Prescribing of mucolytics

Prescribing of triple therapy